Using an example of a patient from our clinic, we outline a framework for assessing and managing the increasingly prevalent finding of pseudo-hypogonadism involving a mild to moderate lowering of serum testosterone concentrations with preservation of normal serum LH and FSH in men with overweight/obesity. Here, BRD2 is linked to obesity due to melanocortin 4 receptor deficiency.